News & Analysis on Clinical Trial Services & Contract Research And Development
Dispatches from BIO 2016
With the emergence of the empowered patient, the reimbursement landscape is shifting and stakeholders must navigate who really holds the power – and how this changes the definition of value.
Hovoine has opened a sales office in Osaka, Japan citing growing demand for generic APIs and manufacturing services.
DISPATCHES FROM BIO 2016
Risk algorithms and international agreements will help ensure imported API quality, says FDA Commissioner Robert Califf but industry must also take responsibility for its own supply chain.
The Office for National Statistics has said that overseas demand drove a monthly increase in the volume of pharmaceuticals made in the UK in April.